// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

THE EFFECT OF AN ESCHERICHIA COLI BACTERIAL URINARY INFECTION ISOLATE AND CIPROFLOXACIN ON CALCIUM UROLITHIASIS IN A DROSOPHILA MELANOGASTER MODEL

Jennifer Bjazevic - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Nephrolithiasis, calcium oxalate

Ciprofloxacin

EFFECT OF A BACTERIAL URINARY INFECTION ISOLATE ON CALCIUM OXALATE CRYSTAL ADHERENCE TO RENAL EPITHELIAL CELLS

Jennifer Bjazevic - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

zinc suspension

COMBINATION OF AN ANTAGONIST TO THE ANDROGEN RECEPTOR N-TERMINAL DOMAIN WITH ENZALUTAMIDE FOR THE TREATMENT OF CASTRATION RESISTANT PROSTATE CANCER

Yukiyoshi Hirayama - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

Enzalutamide

TELEMEDICINE AND HOME MONITORING OF BLADDER FUNCTION FOR MANAGEMENT OF URINARY TRACT INFECTION IN NEUROGENIC BLADDER & SPINAL CORD INJURY

Lynn Stothers - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Urinary tract infections

N/A

EFFICACY OF FESOTERODINE TO AMELIORATE AUTONOMIC DYSREFLEXIA IN PATIENTS WITH SPINAL CORD INJURY SUFFERING FROM NEUROGENIC DETRUSOR OVERACTIVITY

Matthias Walter - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic spinal cord injury

Fesoterodine fumarate

PREDICTING URETERIC STONE EXPULSION WITH PATIENT REPORTED OUTCOMES: A PROSPECTIVE OBSERVATIONAL STUDY

Ryan McLarty - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

TRENDS AND PREDICTORS OF 30 DAY READMISSIONS FOLLOWING PERCUTANEOUS NEPHROLITHOTOMY IN KIDNEY STONES FORMERS AND IMPLICATIONS FOR READMISSIONS-BASED QUALITY METRICS

David-Dan Nguyen - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Nephrolithiasis, calcium oxalate

N/A

THE TREATMENT OF 15-20 MM RENAL CALCULI: A COST-UTILITY ANALYSIS COMPARING FLEXIBLE URETEROSCOPY WITH PERCUTANEOUS NEPHROLITHOTRIPSY

Jonathan Suderman - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Nephrolithiasis, calcium oxalate

N/A

INPATIENT WORKLOAD HAS INCREASED BY UP TO 300% OVER THE LAST DECADE: ANALYSIS OF A UROLOGY RESIDENCY TRAINING PROGRAM FROM 2007-2017

Adam Kinnaird - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

STRESS INCONTINENCE SURGERY IS NOT ASSOCIATED WITH PELVIC MALIGNANCY: THE RESULTS OF A LARGE POPULATION-BASED STUDY

Humberto R Vigil - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

EFFECT OF BARIATRIC SURGERY ON URINARY INCONTINENCE: A SYSTEMATIC REVIEW AND META-ANALYSIS

Yung Lee - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Bladder dysfunction

N/A

MACHINE LEARNING TO PREDICT RECURRENCE OF LOCALIZED RENAL CELL CARCINOMA

Yanbo Guo - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal cell carcinoma

N/A

COMPREHENSIVE ASSESSMENT OF THE MORBIDITY OF RENAL MASS BIOPSY: A POPULATION-BASED ASSESSMENT OF BIOPSY-RELATED COMPLICATIONS

Christopher Wallis - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

DEVELOPMENT AND INITIAL VALIDATION OF A LOW-COST ULTRASOUND-COMPATIBLE SUPRAPUBIC CATHETER INSERTION TRAINING SIMULATOR

Yuding Wang - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

INTRAPERITONEAL ADMINISTRATION OF MESENCHYMAL STEM CELLS IS EFFECTIVE IN PREVENTING DETRUSOR DYSFUNCTION AFTER PARTIAL BLADDER OUTLET OBSTRUCTION

Bridget Waife - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

THE IMPACT OF TRAINING ERA ON THE OUTCOMES OF TRANSURETHRAL PROSTATECTOMY

Jeffrey Campbell - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

WATER II: AQUABLATION THERAPY FOR BENIGN PROSTATIC HYPERPLASIA IN MEN WITH LARGE PROSTATES (80-150CC): 6-MONTH SAFETY AND EFFICACY RESULTS

Naeem Bhojani - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Benign Prostatic Hyperplasia

N/A

ANTIBIOPROPHYLAXIS FOR TRANSRECTAL ULTRASOUND-GUIDED PROSTATE NEEDLE BIOPSY: IS PREVENTION OF POST-PROCEDURAL URINARY SEPSIS IMPROVED WITH THE NOVEL COMBINATION OF CIPROFLOXACIN AND FOSFOMYCIN?

Alexandre Morin - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sepsis

INKP-100

NATURAL HISTORY OF RENAL ANGIOMYOLIPOMA (AML) FAVORS SURVEILLANCE AS AN INITIAL APPROACH

Gregory Nason - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal angiomyolipoma

N/A

RENAL BIOPSY - WHEN WILL IT CHANGE MANAGEMENT?

Douglas Cheung - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved